BioMarin Pharmaceutical
BMRN
#1765
Rank
A$16.71 B
Marketcap
A$86.91
Share price
0.91%
Change (1 day)
-22.72%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): A$1.06 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$3.09 Billion. In 2024 the company made an earning of A$0.77 Billion, an increase over its 2023 earnings that were of A$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.06 B38.53%
2024 A$0.77 B187.31%
2023 A$0.26 B26.07%
2022 A$0.21 B-298.51%
2021 -A$0.11 Billion78.04%
2020 -A$60.18 Million-55.36%
2019 -A$0.14 Billion-33.56%
2018 -A$0.21 Billion297.78%
2017 -A$51.02 Million-95.68%
2016 -A$1.19 Billion437.12%
2015 -A$0.23 Billion23.91%
2014 -A$0.18 Billion-29.25%
2013 -A$0.26 Billion49.23%
2012 -A$0.17 Billion171.11%
2011 -A$62.04 Million103.01%
2010 -A$30.56 Million-3903.54%
2009 A$0.8 M-98.31%
2008 A$47.52 M-189.7%
2007 -A$52.99 Million51.02%
2006 -A$35.09 Million-61.58%
2005 -A$91.31 Million-56.59%
2004 -A$0.22 Billion95.13%
2003 -A$0.11 Billion12.09%
2002 -A$96.16 Million73.19%
2001 -A$55.53 Million18.32%
2000 -A$46.93 Million19.65%
1999 -A$39.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$12.93 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.74 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$39.02 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$7.08 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$0.40 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA